Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanotechnology helps track and improve drug action in pancreatic cancer

Cancer cells (green) spreading through tissue surrounding a tumour
Cancer cells (green) spreading through tissue surrounding a tumour

Abstract:
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny ‘biosensors' along with new advanced imaging techniques.

Nanotechnology helps track and improve drug action in pancreatic cancer

Sydney, Australia | Posted on June 13th, 2013

In real time and in three dimensions, these technologies can show us how cancers spread and how active cancer cells respond to a particular drug. They can also tell us how much, how often and how long to administer drugs. Finally, using preclinical models of the disease, they can guide the use of ‘combination therapies', techniques that enhance drug delivery by breaking up the tissue surrounding a tumour.

The study was performed by Dr Paul Timpson of the Garvan Institute of Medical Research and Professor Kurt Anderson of the Beatson Institute for Cancer Research in Glasgow, UK. PhD student Max Nobis studied the signaling protein ‘Src', which becomes activated to drive invasive pancreatic cancer, and looked at how it could best be deactivated by a small molecule inhibitor — currently in phase II clinical trials — known as ‘dasatinib'. Their findings are published in the journal Cancer Research, now online.

"We have already shown that Src is activated in pancreatic tumours and we knew that dasatinib deactivates Src and could partially reduce the spread of this form of cancer. Through a collaborative partner in the US, we had access to FRET (Fluorescence Resonance Energy Transfer) imaging technology," said Dr Paul Timpson.

"Until now, we have been limited to studying tumour signalling in two dimensions - and lacked a dynamic way of reporting on drug targeting in live tumour tissue. Nanotechnology opens up a portal into living tissue that allows us to watch cancers spreading, and to determine which parts of a tumour we should be targeting with drugs."

"This imaging technology has allowed us to map areas within the tumour that are highly aggressive, allowing us to pinpoint regions of poor drug delivery deep within a tumour at sub-cellular resolution. We can then see where we need to improve on drug delivery to improve clinical outcome."

It has been hard to treat pancreatic tumours because they are extremely dense with collagen and have poor blood vessel networks for delivering drugs.

Professor Kurt Anderson observed that combination therapies can now be used to break down collagen, weakening tumour architecture and making it easier to get the drugs where they need to be. "The trick is to break down the structure just enough to get the drug in, but not so much that you damage the organ itself," he said.

"These new FRET technologies help us gauge what is just enough and not too much."

"These are very exciting discoveries - we now have spatial and temporal information about cancer behaviour that we've never had before, as well as the nanotechnology to monitor and improve drug delivery in hard to reach tumour regions."

####

About Garvan Institute of Medical Research
The Garvan Institute of Medical Research was founded in 1963. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with over 600 scientists, students and support staff. Garvan's main research areas are: Cancer, Diabetes & Obesity, Immunology and Inflammation, Osteoporosis and Bone Biology and Neuroscience. Garvan's mission is to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health. The outcome of Garvan's discoveries is the development of better methods of diagnosis, treatment, and ultimately, prevention of disease.

For more information, please click here

Contacts:
Alison Heather

Science Communications Manager

M: + 61 434 071 326
61-292-958-128

Copyright © Garvan Institute of Medical Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Transparent, electrically conductive network of encapsulated silver nanowires: A novel electrode for optoelectronics August 1st, 2015

Harris & Harris Group Portfolio Company, HZO, Announces Partnerships with Dell and Motorola August 1st, 2015

Advances and Applications in Biosensing, Sensor Power, and Sensor R&D to be Covered at Sensors Global Summit August 1st, 2015

Kalam: versatility personified August 1st, 2015

Imaging

Take a trip through the brain July 30th, 2015

Publication on Atomic Force Microscopy based nanoscale IR Spectroscopy (AFM-IR) persists as a 2015 top downloaded paper July 29th, 2015

Short wavelength plasmons observed in nanotubes: Berkeley Lab researchers create Ludinger liquid plasmons in metallic SWNTs July 28th, 2015

Reshaping the solar spectrum to turn light to electricity: UC Riverside researchers find a way to use the infrared region of the sun's spectrum to make solar cells more efficient July 27th, 2015

Nanomedicine

Heating and cooling with light leads to ultrafast DNA diagnostics July 31st, 2015

European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award: The Award to be presented at BIO-Europe conference in Munich, November 2015 July 30th, 2015

Take a trip through the brain July 30th, 2015

Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015

Sensors

Advances and Applications in Biosensing, Sensor Power, and Sensor R&D to be Covered at Sensors Global Summit August 1st, 2015

Controlling Dynamic Behavior of Carbon Nanosheets in Structures Made Possible July 30th, 2015

Non-Enzyme Sensor Determines Level of Blood Sugar July 29th, 2015

American Chemical Society expands reach to include rapidly emerging area of sensor science July 25th, 2015

Discoveries

Shaping the hilly landscapes of a semi-conductor nanoworld August 1st, 2015

Solid state physics: Quantum matter stuck in unrest August 1st, 2015

Self-assembling, biomimetic membranes may aid water filtration August 1st, 2015

Transparent, electrically conductive network of encapsulated silver nanowires: A novel electrode for optoelectronics August 1st, 2015

Announcements

Self-assembling, biomimetic membranes may aid water filtration August 1st, 2015

Transparent, electrically conductive network of encapsulated silver nanowires: A novel electrode for optoelectronics August 1st, 2015

Harris & Harris Group Portfolio Company, HZO, Announces Partnerships with Dell and Motorola August 1st, 2015

Advances and Applications in Biosensing, Sensor Power, and Sensor R&D to be Covered at Sensors Global Summit August 1st, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project